Dexcom’s revolutionary G6 CGM system is approved to eliminate routine fingersticks
Team Novo Nordisk, the world’s first all-diabetes professional cycling team, and Dexcom, a global leader in development, manufacturing and distribution of continuous glucose monitoring (CGM) systems for diabetes management, announced that all Team Novo Nordisk men’s professional athletes will live, train and race using Dexcom’s new G6 Continuous Glucose Monitoring System.
“Dexcom’s continued focus on innovation and improvement on their already cutting-edge technology is truly heartwarming,” Team Novo Nordisk CEO and Co-Founder Phil Southerland said. “Professional bike racing is a difficult sport without diabetes and the new Dexcom G6 technology will be a huge asset for our riders in their diabetes management, which has a direct impact on performance. Thanks to the support and dedication of Dexcom, we confidently feel that the best is yet to come for Team Novo Nordisk and our mission to inspire, educate and empower everyone affected by diabetes.”
Since 1999, Dexcom’s mission has been to empower people to take control of their diabetes. By constantly tracking their levels with Dexcom’s G6 CGM system, Team Novo Nordisk’s athletes can help eliminate diabetes from the race equation.
The groundbreaking Dexcom G6 incorporates new features including: